Lopinavir-Ritonavir No Benefit in Patients Admitted With COVID-19
No reductions seen in 28-day mortality or duration of hospital stay in COVID-19 with lopinavir-ritonavir
CDC: 2013 to 2018 Saw Jump in Drug OD Deaths Involving Cocaine
Rate of drug OD deaths involving cocaine with opioids increased faster than cocaine deaths without opioids
White House Approves Tougher Rules for COVID-19 Vaccine Development
Guidelines recommend participants in late-stage trials be followed for a median of at least two months
Company Seeks FDA Emergency Approval for COVID-19 Antibody Therapy
Request based on partial clinical trial findings suggesting the drug reduces symptoms in mild or moderate COVID-19
ACS: Antibiotics Noninferior to Appendectomy for Appendicitis
However, complications occurred more often in the antibiotics group than in the appendectomy group
Poll: Only Half of Americans Would Try to Get COVID-19 Vaccine
If enough people in the U.S. pass on vaccine, the nation may not be able to achieve herd immunity
Hydroxychloroquine Not Beneficial for SARS-CoV-2 Preexposure Prophylaxis
No clinical benefit seen versus placebo for hospital-based health care workers exposed to patients with COVID-19
Financial Distress May Increase Suicide Risk in Those With ADHD
New prescriptions for ADHD medications were not associated with financial outcomes
Abemaciclib Beneficial for HR+, HER2− Early Breast Cancer
Significant improvements seen in rates of invasive disease-free survival, distant recurrence-free survival
ASA: Sustained Decrease Seen in Prescription Opioid Abuse in U.S.
Significant declines seen from 2002 to 2013 and 2014 and from 2015 to 2016, 2017, 2018
